CPHD - CEPHEID

CPHD valuation $3.98 billion

Stock Price

56.51
Change: ↑ 2.42 (4.474%)
Last Update: 2015-01-30T16:15:24-05:00
Shares Outstanding: 70,481,243
Industry: Medical Diagnostics & Research

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests.

By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics.

The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures.

Stock Price Data

Open: 56.05 Previous Close: 54.09
High: 58.55 Low: 55.0401
Bid: 56.51 Ask: 57.74

Bid Size: 600 Ask Size: 700
Raw Bid Size: 6 Raw Ask Size: 7
Trade Volume: 11623 Share Volume: 1636832
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:00-05:00
Vwap: 57.1473388 EPS: -0.54

Fundamental Data

PE ratio: PB ratio: 11.016
Beta: 1.062758

52 Week High: 57.47 52 Week Low: 36.94
52 Week High Vwap: 57.4922 52 Week Low Vwap: 37.6291
52 Week High Volume: 3717617 52 Week Low Volume: 149483
52 Week Avg Volume: 641522
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GENE Genetic Technologies Ltd Sponsored ADR 2.79
PKI PerkinElmer Inc. 45.67
A Agilent Technologies Inc. 37.77
BGMD BG Medicine Inc. 1.06
TMO Thermo Fisher Scientific 125.29
APPY Venaxis Inc. 0.51
DGX Quest Diagnostics Inc. 71.15
QGEN Qiagen N.V. 22.93
OXFD Oxford Immunotec Global PLC 11.76
AFFX Affymetrix Inc. 11.04